Compare MDGL & TPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDGL | TPG |
|---|---|---|
| Founded | 2011 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 8.9B |
| IPO Year | N/A | 2022 |
| Metric | MDGL | TPG |
|---|---|---|
| Price | $556.83 | $66.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | ★ $553.08 | $67.00 |
| AVG Volume (30 Days) | 317.0K | ★ 1.8M |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 2.60% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | $740,640,000.00 | ★ $4,255,344,000.00 |
| Revenue This Year | $436.04 | N/A |
| Revenue Next Year | $53.17 | $27.41 |
| P/E Ratio | ★ N/A | $686.34 |
| Revenue Growth | ★ 864.21 | 24.91 |
| 52 Week Low | $265.00 | $37.52 |
| 52 Week High | $605.00 | $70.99 |
| Indicator | MDGL | TPG |
|---|---|---|
| Relative Strength Index (RSI) | 54.32 | 70.70 |
| Support Level | $546.20 | $57.53 |
| Resistance Level | $589.67 | $69.20 |
| Average True Range (ATR) | 20.61 | 1.87 |
| MACD | -6.67 | 0.93 |
| Stochastic Oscillator | 20.49 | 81.63 |
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
TPG Inc is an alternative asset management firm. It invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, Market Solutions, and TPG Angelo Gordon. The company focuses on large-scale, control-oriented private equity investments.